Capital · out
outflows — medical costs (rising MLR from Medicaid/ACA morbidity) dominate; then ~$2.6B buybacks + ~$1.5B dividends FY25
Sourced figures 1
- stockanalysis.com ELV cash-flow statement share repurchases $2,605M; dividends paid $1,529M FY25; FCF $3,174M FY25
the working
Threads 1
A claim is one metric we assert about a node — the value is the summary, this page is the receipt. Sourced from kestrel; supersedes-history not yet shown. Back to Elevance Health.